Targeting Bacterial Genomes for Natural Product Discovery

Area of Science:

• Microbiology
• Bioinformatics
• Drug Discovery

Background:

• Bacterial natural products (NPs) are crucial sources for small molecule drugs, with over half of recent approvals originating from this area.
• Despite the success of NPs, major pharmaceutical companies have shown reduced interest, coinciding with genomic discoveries of numerous biosynthetic gene clusters (BGCs) encoding novel compounds.
• Current limitations exist in universal strategies and technologies for large-scale, high-speed natural product discovery.

Purpose of the Study:

• To review the opportunities presented by genome sequencing and bioinformatics for natural product discovery.
• To discuss the challenges in translating genomic data into the identification and production of novel natural products.
• To highlight successful strategies for strain prioritization and BGC activation in the genomic era.

Main Methods:

• Genome sequencing and bioinformatics analysis to identify BGCs.
• Development of enabling technologies for natural product discovery.
• Implementation of strain prioritization and BGC activation strategies.

Main Results:

• Genomics has uncovered a vast number of BGCs encoding potential novel natural products.
• Challenges remain in efficiently accessing and activating these BGCs for compound production.
• Successful examples demonstrate the potential of combining genomic insights with targeted activation strategies.

Conclusions:

• Genome sequencing and bioinformatics offer significant opportunities for discovering novel bacterial natural products.
• Overcoming challenges in BGC activation and strain selection is key to unlocking the full potential of microbial genomics for drug discovery.
• Developing scalable and rapid discovery platforms is essential for the future of natural product research.